Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States

被引:8
|
作者
Su, Jun [1 ]
Bylsma, Lauren C. [2 ]
Jiang, Xiaohui [2 ]
Morales Arias, Jaime [1 ]
Jain, Nisha [1 ]
Nordyke, Robert J. [3 ]
机构
[1] Sanofi, 50 Binney St, Cambridge, MA 02142 USA
[2] EpidStrategies, Ann Arbor, MI USA
[3] Beta6 Consulting Grp, Los Angeles, CA USA
关键词
Disease burden; healthcare resource utilization; cold agglutinin disease; autoimmune hemolytic anemia; database analysis; BURDEN; ANEMIA; COSTS;
D O I
10.1080/13696998.2020.1764006
中图分类号
F [经济];
学科分类号
02 ;
摘要
Aims: Cold agglutinin disease (CAD) is a rare subtype of autoimmune hemolytic anemia associated with increased thromboembolism risk and early mortality. Healthcare resource utilization (HRU) in CAD has not been reported. We aimed to compare HRU of patients with CAD with a matched non-CAD cohort in the United States. Materials and methods: Patients with CAD were identified from 2006 to 2016 in the Optum-Humedica database using CAD terms in clinical notes and hematologist review. Patients were required to have Integrated Delivery Network records and >= 6 months' follow-up before and after the first CAD mention date (index date). Patients with CAD were matched to a non-CAD cohort based on demographics. Multivariate analyses assessed inpatient hospitalizations, outpatient visits, emergency room visits, and transfusion use between cohorts 6 months before and 12 months after the index date. Results: Of 814 patients with CAD, 410 met inclusion criteria and were matched to 3,390 patients without CAD. Mean age of patients with CAD was 68.0 years; approximately 62% were female. In the 12 months after the index date, mean inpatient hospitalizations (0.83 vs. 0.25), outpatient visits (17.26 vs. 6.77), emergency room visits (0.55 vs. 0.32), and transfusion days (1.05 vs. 0.05) were higher for patients with CAD than the matched non-CAD cohort (all p < .0001). Similarly, in the 6 months before the index date, patients with CAD had higher HRU than matched patients without CAD for all measures evaluated. Limitations: Results of this study are based on patient information from the Optum-Humedica database, which is limited to commercially insured patients and may not represent the overall CAD population. Conclusions: CAD places a substantial burden on patients and healthcare systems. In addition, the high HRU for patients with CAD observed in the 6 months before diagnosis indicates that disease awareness and better diagnostic practices may be needed.
引用
收藏
页码:902 / 907
页数:6
相关论文
共 50 条
  • [1] HEALTHCARE RESOURCE UTILIZATION AMONG COMMERCIALLY INSURED COLD AGGLUTININ DISEASE PATIENTS IN THE UNITED STATES
    Su, J.
    Bylsma, L. C.
    Jiang, X.
    Arias, Morales J.
    Jain, N.
    Nordyke, R.
    VALUE IN HEALTH, 2019, 22 : S348 - S348
  • [2] Healthcare Resource Utilization and Costs Associated With Eosinophilic Esophagitis Among Commercially Insured Patients in the United States
    Xia, Qian
    Tencer, Tom
    Jobson, Greeta
    Qian, Ellen
    Dellon, Evan S.
    Biswas, Mousumi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (11): : 2326 - 2330
  • [3] Healthcare resource utilization among patients with cold agglutinin disease in Denmark
    Vago, Emese K.
    Nicholson, Gina
    Horvath-Puho, Erzsebet
    Hooda, Naushin
    Fryzek, Jon P.
    Su, Jun
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (10) : 1829 - 1835
  • [4] HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG COMMERCIALLY INSURED PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN THE UNITED STATES
    Bonafede, M. M.
    McMorrow, D.
    Marshall, A.
    Gupta, K.
    Pazirandeh, M.
    VALUE IN HEALTH, 2018, 21 : S125 - S125
  • [5] Seasonal Patterns of Anemia, Hemolytic Markers and Healthcare Resource Utilization Among Patients Cold Agglutinin Disease in the United States: A Retrospective Analysis
    Roeth, Alexander
    Fryzek, Jon
    Jiang, Xiaohui
    Morales, Jaime
    Broome, Catherine M.
    BLOOD, 2018, 132
  • [6] HEALTHCARE RESOURCE UTILIZATION (HRU) AMONG PATIENTS WITH COLD AGGLUTININ DISEASE (CAD) IN DENMARK
    Vago, E. K.
    Nicholson, G.
    Horvath-Puho, E.
    Fryzek, J. P.
    Su, J.
    VALUE IN HEALTH, 2020, 23 : S697 - S697
  • [7] The Epidemiology, Clinical Outcomes, and Healthcare Resource Utilization of IgG4-Related Disease Among Commercially Insured People in the United States
    Wallace, Zachary
    Miles, Gandarvaka
    Smolkina, Ekaterina
    Petruski-Ivleva, Natalia
    Madziva, Duane
    Cook, Claire
    Fu, Xiaoqing
    Zhang, Yuqing
    Stone, John
    Choi, Hyon
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1425 - 1428
  • [8] HEALTHCARE COST AND UTILIZATION OF HEPATIC ENCEPHALOPATHY: ANALYSIS OF COMMERCIALLY INSURED PATIENTS IN THE UNITED STATES
    Elsaid, Mohamed I.
    Li, You
    John, Tina
    Pentakota, Ram
    Rustgi, Vinod K.
    HEPATOLOGY, 2019, 70 : 261A - 261A
  • [9] Patterns of treatment and healthcare resource utilization among commercially insured patients with diabetic neuropathy
    Zhao, Yang
    Bao, Yanjun
    Boulanger, Luke
    Ye, Wenyu
    Boye, Kristina S.
    Russell, Mason
    DIABETES, 2008, 57 : A228 - A228
  • [10] BURDEN OF ILLNESS, ANNUAL HEALTHCARE UTILIZATION, AND COSTS ASSOCIATED WITH COMMERCIALLY INSURED PATIENTS WITH CUSHING DISEASE IN THE UNITED STATES
    Broder, Michael S.
    Neary, Maureen P.
    Chang, Eunice
    Cherepanov, Dasha
    Ludlam, William H.
    ENDOCRINE PRACTICE, 2015, 21 (01) : 77 - 86